Country: Ísrael
Tungumál: enska
Heimild: Ministry of Health
XYLOMETAZOLINE HYDROCHLORIDE
GSK CONSUMER HEALTHCARE, ISRAEL LTD
R01AA07
SOLUTION
XYLOMETAZOLINE HYDROCHLORIDE 0.1 %W/V
NASAL
Not required
GSK CONSUMER HEALTHCARE SCHWEIZ AG, SWITZERLAND
XYLOMETAZOLINE
XYLOMETAZOLINE
Nasal congestion in acute colds, vasomotor rhinitis, hay fever, rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older.
2023-01-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS ’ REGULATIONS ) PREPARATIONS ( – This edi i e is dispesed ithout a do to ’s pes iptio OTII METHOL .% / IT A ASAL SOLUTIO THE ATIE I G EDIE T A D ITS O E TATIO : X lo etazoli e HCl . % / Iatie i g ediets ad alleges i the p epaatio – please see se tio ad setio ) Ipo tat i fo atio aout so e i g ediets of the edi i e ( . READ THE ETIE LEAFLET A EFULL EFO E USI G THE EDI I E. This leaflet o tai s o ise i fo atio aout the edi i e. If ou ha e a othe uestios, efe to the do to o the phaaist. Use the p epaatio ao di g to the i stutio s i the dosage se tio of this leaflet. Co sult the phaaist if ou eed o e i fo atio. Refe to the do to if sig s of the ail e t ) s pto s ( o se o do ot i p o e afte DA S. . WHAT IS THE EDI I E I TE DED FO ? The edi i e is i teded fo apid elief of asal o gestio fo up to hou s i adults ad adolesets o e eas old. Theapeuti lass: Ot i i Methol o tai s lo etazoli e h d o hlo ide, hi h elo gs to the s patho i eti agets g oup. It also o tai s ethol ad eu al ptus. . BEFO E USI G THE EDI I E Do ot use this pepaatio if: • You ae sesiti e ) alle gi ( to the atie i g ediet ) lo etazoli e h d o hlo ide ( o to a of the othe o po ets the edi i e o tai s ) see setio ( . • You ha e ao agle glau o a. • You ha e had a tas-spheoidal ) ia the asal a it ( ese tio of the pituita o a opeatio du i g hi h the oute e i ges of the etal e ous s ste as e posed. • You ha e h o i asal i fla atio ith e d asal passages ) hi itis si a o atophi hi itis ( . • Do ot use the pepaatio i hild e ude the age of eas. SPE IAL A I GS EGA DI G THE USE OF THE EDI I E: BEFO E T EAT ET ITH OT I I ME THOL, I FO THE DO TO IF: • You ha e high lood pessu e. • You ha e a heat disease o lo g QT s d o e. • You ha e a o eatie th oid. • You ha e dia etes. • You ha e a elaged p ostate. • You ha e a ae tuo i the ad eal glad that p odu es e ess ad eali e ad o ad eali e ) pheo ho o to a ( . • If ou ae taki g ati-depessats, suh as: - Mo oai e o idase i hi ito s ) MAOIs ( , do Lestu allt skjalið
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Otrivin Menthol 0.1% w/v, Nasal spray 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Otrivin Menthol 0.1%w/v metered-dose spray Each ml of metered-dose spray contains 1 mg of xylometazoline hydrochloride. Excipients with known effect: Benzalkonium chloride: 0.1 mg/ml. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal, solution. Opalescent, w h ite solution, with an odor of menthol and eucalyptol. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Nasal congestion in acute colds, vasomotor rhinitis, hay fever, rapid relief of nasal congestion for up to ten hours in adults and adolescents aged 12 years and older. 4.2 Posology and method of administration Otrivin Menthol should not be used in children aged less than 12 years old. Method of administration: Otrivin nasal metered-dose spray Age Posology Adults and adolescents over 12 years of age 1 spray into each nostril, 3 times daily as needed. Leave an interval of 8 to 10 hours between doses. Do not exceed a maximum of 3 applications daily into each nostril. The metered-dose spray allows you to apply an exact dose and ensures that the solution is evenly distributed on the surface of the nasal mucosa. It prevents the likelihood of an unintentional overdose. Each puff of Otrivin Menthol delivers 0.14 mL (0.14 mg of xylometazoline hydrochloride). Before first use, press the spray pump 4 times. Once full, the pump will remain charged for the period of regular daily use. If spraying does not occur when the pump is fully pressed, or is not used for more than 7 days, it must be refilled by pressing the pump 4 times as done before the first use. It is recommended to make the last application shortly before bedtime. Be careful not to bring into contact with your eyes. 1. Clear the nose gently. 2. Remove protective cap. 3. Do not cut the nozzle. The metered dose spray is ready to prime before use. 4. Hold the bottle upright with thumb under base and nozzle between two fingers. 5. Lean fo Lestu allt skjalið